earnings
confidence high
sentiment neutral
materiality 0.75
AdaptHealth Q4/FY2023 revenue up 7.7% to $3.2B, net loss $678.9M from goodwill impairment; guides 2024
AdaptHealth Corp.
2023-FY EPS reported
-$5.31
revenue$3,200,177,000
- FY2023 net revenue $3,200.2M (+7.7% YoY); net loss $678.9M vs $69.3M profit, driven by $830.8M pretax goodwill impairment.
- Q4 net revenue $858.2M (+10%); adjusted EBITDA $204.6M (+40.2%).
- FY2023 adjusted EBITDA $670.8M (+13%); free cash flow $143.2M vs ($17.6M) prior year.
- Initial FY2024 guidance: net revenue $3.25-3.35B, adjusted EBITDA $650-710M, free cash flow $150-180M.
- Leverage ratio improved to 3.16x from 3.69x year-end 2022.